Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
CT-P59（一种针对SARS-CoV-2刺突受体结合蛋白的中和单克隆抗体）的安全性、病毒学疗效和药代动力学：两项在健康个体和轻症SARS-CoV-2感染患者中进行的随机、安慰剂对照I期研究
期刊:Clinical Therapeutics
影响因子:3.6
doi:10.1016/j.clinthera.2021.08.009
Kim, Jin Yong; Jang, Young Rock; Hong, Jang Hee; Jung, Jin Gyu; Park, Jae-Hyeong; Streinu-Cercel, Adrian; Streinu-Cercel, Anca; Săndulescu, Oana; Lee, Sang Joon; Kim, Sung Hyun; Jung, Na Hyun; Lee, Seul Gi; Park, Jeong Eun; Kim, Min Kyung; Jeon, Da Bee; Lee, Yeo Jin; Kim, Bum Soo; Lee, Yeon Mi; Kim, Yeon-Sook
信号转导
微生物学
单克隆抗体
SARS-CoV-2
炎症/感染
